| Product Code: ETC9949141 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Molecular Imaging Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Molecular Imaging Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Molecular Imaging Market - Industry Life Cycle |
3.4 United Kingdom (UK) Molecular Imaging Market - Porter's Five Forces |
3.5 United Kingdom (UK) Molecular Imaging Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 United Kingdom (UK) Molecular Imaging Market Revenues & Volume Share, By Device Type, 2021 & 2031F |
3.7 United Kingdom (UK) Molecular Imaging Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 United Kingdom (UK) Molecular Imaging Market Revenues & Volume Share, By End users, 2021 & 2031F |
4 United Kingdom (UK) Molecular Imaging Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring early diagnosis and monitoring through molecular imaging |
4.2.2 Technological advancements leading to the development of innovative imaging techniques |
4.2.3 Growing awareness among healthcare professionals and patients about the benefits of molecular imaging |
4.3 Market Restraints |
4.3.1 High costs associated with molecular imaging equipment and procedures |
4.3.2 Limited reimbursement policies for molecular imaging services |
4.3.3 Regulatory challenges and stringent approval processes for new imaging technologies |
5 United Kingdom (UK) Molecular Imaging Market Trends |
6 United Kingdom (UK) Molecular Imaging Market, By Types |
6.1 United Kingdom (UK) Molecular Imaging Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Molecular Imaging Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 United Kingdom (UK) Molecular Imaging Market Revenues & Volume, By Magnetic Resonance Spectroscopy, 2021- 2031F |
6.1.4 United Kingdom (UK) Molecular Imaging Market Revenues & Volume, By Optical Imaging, 2021- 2031F |
6.1.5 United Kingdom (UK) Molecular Imaging Market Revenues & Volume, By Molecular Ultrasound Imaging, 2021- 2031F |
6.2 United Kingdom (UK) Molecular Imaging Market, By Device Type |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Molecular Imaging Market Revenues & Volume, By Positron Emission Tomography (PET) Scanner, 2021- 2031F |
6.2.3 United Kingdom (UK) Molecular Imaging Market Revenues & Volume, By Single Photon Emission Computed Tomography (SPECT) Scanner, 2021- 2031F |
6.2.4 United Kingdom (UK) Molecular Imaging Market Revenues & Volume, By Gamma Camera, Nuclear Magnetic Resonance (NMR) Spectrometer, 2021- 2031F |
6.2.5 United Kingdom (UK) Molecular Imaging Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United Kingdom (UK) Molecular Imaging Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Molecular Imaging Market Revenues & Volume, By Cardiovascular, 2021- 2031F |
6.3.3 United Kingdom (UK) Molecular Imaging Market Revenues & Volume, By Neurology, 2021- 2031F |
6.3.4 United Kingdom (UK) Molecular Imaging Market Revenues & Volume, By Respiratory, 2021- 2031F |
6.3.5 United Kingdom (UK) Molecular Imaging Market Revenues & Volume, By Oncology, 2021- 2031F |
6.3.6 United Kingdom (UK) Molecular Imaging Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United Kingdom (UK) Molecular Imaging Market, By End users |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Molecular Imaging Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 United Kingdom (UK) Molecular Imaging Market Revenues & Volume, By Diagnostic Imaging Centers, 2021- 2031F |
6.4.4 United Kingdom (UK) Molecular Imaging Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
6.4.5 United Kingdom (UK) Molecular Imaging Market Revenues & Volume, By Others, 2021- 2031F |
7 United Kingdom (UK) Molecular Imaging Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Molecular Imaging Market Export to Major Countries |
7.2 United Kingdom (UK) Molecular Imaging Market Imports from Major Countries |
8 United Kingdom (UK) Molecular Imaging Market Key Performance Indicators |
8.1 Adoption rate of new molecular imaging technologies in clinical practice |
8.2 Number of research studies and publications utilizing molecular imaging techniques in the UK |
8.3 Investment in research and development for molecular imaging technologies in the UK |
9 United Kingdom (UK) Molecular Imaging Market - Opportunity Assessment |
9.1 United Kingdom (UK) Molecular Imaging Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 United Kingdom (UK) Molecular Imaging Market Opportunity Assessment, By Device Type, 2021 & 2031F |
9.3 United Kingdom (UK) Molecular Imaging Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 United Kingdom (UK) Molecular Imaging Market Opportunity Assessment, By End users, 2021 & 2031F |
10 United Kingdom (UK) Molecular Imaging Market - Competitive Landscape |
10.1 United Kingdom (UK) Molecular Imaging Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Molecular Imaging Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here